In continuation of its intimation dated July 29, 2026, and pursuant to the provisions of Regulations 30 and 33 of the Listing Regulations, Park Medi World has informed that the Board of Directors of Company in its meeting held today, Monday, August 03, 2026, has considered and approved the following items: 1. Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended on June 30, 2026. The Financial Results along with the Limited Review Report are enclosed as Annexure-I. 2. Acquisition of ‘Mehar Hospital-Zirakpur’, owned and operated by Mehar Mediserve LLP. The details as required under the Listing Regulations read with SEBI circular HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026, along with the press release towards the aforesaid acquisition are enclosed as Annexure -II. 3. Variation in the objects of the Initial Public Offer Proceeds as stated in the Prospectus dated December 12, 2025, subject to approval of the Shareholders by way of Postal Ballot and the notice for obtaining shareholders’ approval for the proposed Variation will be sent to the Shareholders of the Company and the Stock Exchanges in due course. Further details of the Proposed Variation will be set out in the explanatory statement forming part of the notice. The meeting of the Board of Directors of the Company commenced at 08:00 AM (IST) and concluded at 09:20 am (IST). The financial results will also be available on the Company's website at https://www.parkhospital.in/.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 8565.00 |
| Max Healthcare Inst. | 1008.00 |
| Narayana Hrudayalay. | 1830.90 |
| Aster DM Quality | 829.60 |
| Global Health | 1394.95 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: